Incyte acquires Vega Therapeutics for $1.25B upfront Jul 6, 2026 08:39AM
Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio Jul 6, 2026 08:39AM
Incyte to acquire Vega Therapeutics for $1.25 billion upfront Jun 8, 2026 07:00AM
Incyte to Acquire Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio into Bleeding Disorders Jun 8, 2026 07:00AM
Trading Radar for 05/01: Exxon (XOM), Kraft Foods (KRFT), T-Mobile (TMUS), Expedia (EXPE), Western Union (WU) Report Apr 30, 2014 02:59PM


Jan 14, 2013 06:59AM Lazard Capital Upgrades Incyte (INCY) to Buy
Aug 7, 2012 07:50AM Lazard Capital Starts Incyte (INCY) at Neutral
Oct 26, 2011 05:30PM Trading Radar for 10/27: Exxon (XOM), Dow Chemical (DOW), Baidu.com (BIDU), Procter & Gamble (PG), AMD (AMD) Report
May 17, 2011 11:15AM George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)